Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Washington State University · with Terra Mater Botanicals Pty Ltd · NCT07393672
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–60 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 104
- US sites recruiting
- 1
- Study start
- February 11, 2026
- Record last updated
- March 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Being studied: Hemp-derived cannabinoids; Placebo
Conditions: Menopause; Perimenopause
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- designated female at birth
- 40-60 years of age
- able to give informed consent (no intellectual disability)
- stable pharmacotherapeutic regimen, no change in the past 3 months
- abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use for 3 months
- abstinent for supplements, don't add any supplements (no changes in past 3 months)
- own a smartphone
- have access to Zoom on a secure, stable internet connection
- perimenopausal or menopausal
Exclusion Criteria
- currently taking anti-depressant, anti-anxiety, and/or antipsychotic medication
- severe depression, neurovegetative symptoms, or current suicidality
- psychosis or family history of psychosis
- pregnant or breastfeeding
- chemotherapy
- hypotension
- drug testing for work or other reasons
- illicit drug use in past 3 months (cannabis not illicit)
- heavy alcohol use (4 drinks more than 4x/week)
- international/air travel planned for more than one week in the next 3 months
- cocounut allergy
Recruiting US locations
Washington State University, Dept of Psychology
Pullman, WA 99164
Site contact: Carrie Cuttler, PhD · 509-592-0151 · carrie.cuttler@wsu.edu
Study contacts (from the official record)
- Carrie Cuttler, PhD · (509) 592-0151 · carrie.cuttler@wsu.edu
Similar studies in Washington
All sleep studies in Washington →- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
Alkermes, Inc.
- Location
- Spokane, WA + 14 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- Renton, WA + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Janssen Research & Development, LLC
- Location
- Everett, WA + 41 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Harmony Biosciences Management, Inc.
- Location
- Spokane, WA + 39 other US sites
- Eligibility basics
- Ages 18+